Anaemia as a contributor to morbidity and mortality in congestive heart failure

Nephrology Dialysis Transplantation

Volumn 20, Issue SUPPL. 7, 2005, Pages

  Wexler, Dov ^a   Silverberg, Donald ^a   Blum, Miriam ^a   Sheps, David ^a   Keren, Gad ^a   Wollman, Yoram ^a   Schwartz, Doron ^a   Iaina, Adrian ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Anaemia; Erythropoietin; Heart failure; Iron; Kidney failure

Indexed keywords

DIURETIC AGENT; ERYTHROPOIETIN; FERRIC HYDROXIDE SUCROSE; IRON;

ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DISEASE COURSE; DRUG MEGADOSE; ERYTHROCYTE VOLUME; EXERCISE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; HYPONATREMIA; KIDNEY FUNCTION; MALNUTRITION; MEDICAL SPECIALIST; MORBIDITY; MORTALITY; PLASMA VOLUME; PRIORITY JOURNAL; QUALITY OF LIFE;

ANEMIA; DISEASE PROGRESSION; HEART FAILURE; HUMANS; RENAL INSUFFICIENCY, CHRONIC; SYNDROME;

EID: 27144464474     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfh1101     Document Type: Article

References (41)

1. Miller LW, Missov ED. Epidemiology of heart failure. Cardiol Clin 2001; 19: 547-555
2. Levy D, Kenchaiah S, Larson MG et al. Long term trends in the incidence of and survival with heart failure. N Engl J Med 2002; 347: 1397-1402
3. Cleland FGF, Cohen-Solal A, Aguillar JC et al. Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): An international survey. Lancet 2002; 360: 1631-1639
4. Stafford RS, Radley DC. The underutilization of cardiac medications of proven benefit, 1990-2002. J Am Coll Cardiol 2003; 41: 56-61
5. Silverberg DS, Wexler D, Blum M, Iaina A. The cardio renal anemia syndrome: Correcting anemia inpatients with resistant congestive heart failure can improve both cardiac and renal function and reduces hospitalization. Clin Nephrol 2003; 60 [Suppl 1]: S93-S102
6. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function, functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-1744
7. Kosiborod M, Smith GL, Radford MJ et al. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114: 112-119
8. Al-Ahmad A, Rand WM, Manjunath G et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001; 38: 955-962
9. McClellan WM, Flanders WD, Langston RD et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: A population-based study. J Am Soc Nephrol 2002; 13: 1928-1936
10. Horwich TB, Fonarow GC, Hamilton MA et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786
11. Ezekowitz J, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation 2003; 107: 223-225
12. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure. J Am Coll Cardiol 2003; 41: 1933-1939
13. Androne AS, Katz SD, Lund L et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226-229
14. Kalra PR, Bolger AP, Francis DP et al. Effect of anemia on exercise tolerance in chronic heart failure. Am J Cardiol 2003; 91: 888-891
15. Kalra PR, Collier T, Cowie MR et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 2003; 362: 211-212
16. Gilbertson, D, Li S, Murray AM, Herzog CA, Collins AJ. Competing risks of death vs ESRD in Medicare beneficiaries age 65+ with chronic kidney disease, CHF and anemia. J Am Soc Nephrol 2002; 13: SA848 [abstract]
17. Silverberg DS, Wexler WD, Sheps D et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: A randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780
18. Silverberg DS, Wexler D, Blum M et al. The effect of correction of anemia in diabetic and non diabetics with severe resistant congestive heart failure and chronic renal failure by subcutanous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003; 18: 141-146
19. Mancini DM, Katz SD, Lang C et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation 2003; 107: 294-299
20. Macin SM, Perna ER, Farias EF et al. Anemia is a highly prevalent condition in decompensated heart failure with prognostic implication. Eur J Heart Fail Suppl 2003; 2: 295A
21. Anand IS, Chandrashekhar Y, Ferrari R, Poole-Wilson PA, Harris PC. Pathogenesis of oedema in chronic anemia: Studies of body water and sodium, renal function, haemodynamics and plasma hormones. Br Heart J 1993; 70: 357-362
22. Johnson DB, Dell'Italia LJ. Cardiac hypertrophy and failure in hypertension. Curr Opin Nephrol Hypertens 1996; 5: 186-191
23. Katz AM. The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart. Ann Intern Med 1994; 121: 363-371
24. Grune T, Sommerburg O, Siems WG. Oxidative stress in anemia. Clin Nephrol 2000; 53 [Suppl 1]: S18-S22
25. Siems WG, Sommerburg O, Grune T. Erythrocyte free radical and energy formation. Clin Nephrol 2000; 53 [Suppl 1]: S9-S17
26. Iverson PO, Woldbaek PR, Tonnessen T, Christensen G. Decreased hematopoiesis in bone marrow of mice with congestive heart failure. Am J Physiol 2002; 282: R166-R172
27. Herrera-Garza EH, Stetson SJ, Cubillos-Garzon A, Vooltich MT, Farmer JA, Torre-Amione G. Tumor necrosis factor: A mediator of disease progression in the failing human heart. Chest 1999; 115: 1170-1174
28. Means RT. Advances in the anemia of chronic disease. Int J Hematol 1999; 70: 7-12
29. Bolger AP, Doehner W, Sharma R, Coate JS, Anker S. Anemia in chronic heart failure: The relationship to inflammatory cytokine production and prognostic importance. Circulation 2002; 106 [Suppl]: 2819A [abstract]
30. Vaziri ND Erythropoietin and transferrin metabolism in nephrotic syndrome. Am J Kidney Dis 2001; 38: 1-8
31. Macdougall IC. The role of ACE inhibitors and angiotensin II receptor blockers in the response to erythropoietin. Nephrol Dial Transplant 1999; 14: 1836-1841
32. Fine L, Dandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int 2000; 57 [Suppl 75]: S22-S26
33. Yu HT. Progression of chronic renal failure. Arch Intern Med 2003; 163: 1417-1429
34. Amann K, Ritz C, Adamczak M, Ritz E. Why is coronary heart disease of uraemic patients so frequent and so devastating? Nephrol Dial Transplant 2003; 18: 631-640
35. Zoccali C, Mallamaci F, Tripepi G. Traditional and emerging cardiovascular risk factors in end-stage renal disease. Kidney Int 2003; 63 [Suppl 85]: S105-S110
36. McCullough PA, Why is chronic kidney disease the 'spoiler' for cardiovascular disease outcomes? J Am Coll Cardiol 2003; 41: 725-728
37. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: No longer a simple plumbing question. J Am Soc Nephrol 2003; 14: 1927-1939
38. Mann JFE, Gerstein HC, Dulau-Florea I, Lonn E. Cardiovascular risk in patients with mild renal insufficiency. Kidney Int 2003; 63 [Suppl 84]: S192-S196
39. Tyralla K, Amann K. Morphology of the heart and arteries in renal failure. Kidney Int 2003; 63 [Suppl 84]: S80-S83
40. Herzog CA, Ma JZ, Collins AJ. Poor long term survival after acute myocardial infarction among patients on long term dialysis. N Engl J Med 1998; 339: 799-805
41. Tang WHW, Miller H, Partin M et al. Anemia in ambulatory patients with chronic heart failure: A single-center clinical experience derived from electronic medical records. J Am Coll Cardiol 2003; 41 [Suppl A]: 157A [abstract]